Cargando…

Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol

A 35-year-old female with pulmonary arterial hypertension (PAH) who presented with complaints of progressively worsening dysphagia, facial swelling, and shortness of breath, was found to have a large goiter. In patients treated with epoprostenol for long periods of time, thyroid disease is common. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Abughazaleh, Shaadi, Safdar, Zeenat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998745/
https://www.ncbi.nlm.nih.gov/pubmed/32082680
http://dx.doi.org/10.1155/2020/1617253
_version_ 1783493889874722816
author Abughazaleh, Shaadi
Safdar, Zeenat
author_facet Abughazaleh, Shaadi
Safdar, Zeenat
author_sort Abughazaleh, Shaadi
collection PubMed
description A 35-year-old female with pulmonary arterial hypertension (PAH) who presented with complaints of progressively worsening dysphagia, facial swelling, and shortness of breath, was found to have a large goiter. In patients treated with epoprostenol for long periods of time, thyroid disease is common. Most cases of thyroid disease describe thyrotoxicosis and hyperthyroid statues, but our case was a patient on long term IV epoprostenol presenting with a superior vena cava-syndrome (SVC) like appearance and airway compromise found to have a goiter incidentally during workup.
format Online
Article
Text
id pubmed-6998745
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-69987452020-02-20 Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol Abughazaleh, Shaadi Safdar, Zeenat Case Rep Pulmonol Case Report A 35-year-old female with pulmonary arterial hypertension (PAH) who presented with complaints of progressively worsening dysphagia, facial swelling, and shortness of breath, was found to have a large goiter. In patients treated with epoprostenol for long periods of time, thyroid disease is common. Most cases of thyroid disease describe thyrotoxicosis and hyperthyroid statues, but our case was a patient on long term IV epoprostenol presenting with a superior vena cava-syndrome (SVC) like appearance and airway compromise found to have a goiter incidentally during workup. Hindawi 2020-01-23 /pmc/articles/PMC6998745/ /pubmed/32082680 http://dx.doi.org/10.1155/2020/1617253 Text en Copyright © 2020 Shaadi Abughazaleh and Zeenat Safdar. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Abughazaleh, Shaadi
Safdar, Zeenat
Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol
title Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol
title_full Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol
title_fullStr Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol
title_full_unstemmed Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol
title_short Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol
title_sort goiter in a patient with pulmonary arterial hypertension treated with epoprostenol
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998745/
https://www.ncbi.nlm.nih.gov/pubmed/32082680
http://dx.doi.org/10.1155/2020/1617253
work_keys_str_mv AT abughazalehshaadi goiterinapatientwithpulmonaryarterialhypertensiontreatedwithepoprostenol
AT safdarzeenat goiterinapatientwithpulmonaryarterialhypertensiontreatedwithepoprostenol